DEEPAKNTR stock
DEEPAKNTR is showing a constructive news setup around Chemicals, with 1 recent story and improving sentiment breadth.
DEEPAKNTR has built a constructive coverage cluster in the last 1 day. The strongest recurring theme is Chemicals, while the current weighted impact score is +72 from 1 bullish, 0 bearish, and 0 neutral stories across 1 sources.
DEEPAKNTR is last saved at ₹1,751 with a day move of +0.32%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
This is the first public financial report for DEEPAKNTR. The company reported sales of ₹1903.4 crore and made a profit of ₹98.13 crore. These numbers show how much money the company made and kept, which helps you understand its business performance. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 26 days ago · 2 min read
Economic Times · 15 Jun 2026 · 2 min read
Economic Times · 17 Mar 2026 · 2 min read
Economic Times · 16 Mar 2026 · 2 min read
Economic Times · 12 Mar 2026 · 2 min read
How DEEPAKNTR stacks against related names in this news cluster
DEEPAKNTR has appeared across 1 recent stories from 1 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
DEEPAKNTR coverage is currently leaning bullish, with 1 bullish, 0 bearish, and 0 neutral analyzed stories in the recent window.
Recent DEEPAKNTR coverage is clustering around Chemicals. Related names showing up alongside DEEPAKNTR include the wider peer basket.
Use this page as a coverage hub for DEEPAKNTR: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
How retail crowds and channels are talking about DEEPAKNTR right now — context for your own research, not a trade call.